tiprankstipranks
SHAREHOLDER ALERT: Potential Recovery for Repare Therapeutics Inc. (RPTX) Investors
PremiumClass ActionSHAREHOLDER ALERT: Potential Recovery for Repare Therapeutics Inc. (RPTX) Investors
3M ago
Repare Therapeutics Reports Promising 2023 Progress
PremiumCompany Announcements
Repare Therapeutics Reports Promising 2023 Progress
3M ago
Repare Therapeutics reports Q4 EPS (67c), consensus (46c)
PremiumThe Fly
Repare Therapeutics reports Q4 EPS (67c), consensus (46c)
3M ago
Repare Therapeutics to regain global rights to Camonsertib
PremiumThe FlyRepare Therapeutics to regain global rights to Camonsertib
3M ago
Repare Therapeutics Receives Milestone Payment from Roche
PremiumMarket News
Repare Therapeutics Receives Milestone Payment from Roche
4M ago
Capital One says buy these six biotech stocks for 2024
PremiumThe Fly
Capital One says buy these six biotech stocks for 2024
4M ago
Repare Therapeutics pipeline with 4 clinical-stage programs by 2H24
PremiumThe FlyRepare Therapeutics pipeline with 4 clinical-stage programs by 2H24
4M ago
Repare enters into clinical study, collaboration pact with Debiopharm
PremiumThe Fly
Repare enters into clinical study, collaboration pact with Debiopharm
4M ago
Repare Therapeutics price target lowered to $8 from $14 at Morgan Stanley
PremiumThe Fly
Repare Therapeutics price target lowered to $8 from $14 at Morgan Stanley
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100